Literature DB >> 21658638

Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients.

Carla Colombo1, Helmut Ellemunter, Roderick Houwen, Anne Munck, Chris Taylor, Michael Wilschanski.   

Abstract

Complete or incomplete intestinal obstruction by viscid faecal material in the terminal ileum and proximal colon - distal intestinal obstruction syndrome (DIOS) - is a common complication in cystic fibrosis. Estimates of prevalence range from 5 to 12 episodes per 1000 patients per year in children, with higher rates reported in adults. DIOS is mainly seen in patients with pancreatic insufficiency, positive history of meconium ileus and previous episodes of DIOS. DIOS is being described with increasing frequency following organ transplantation. Diagnosis is based on suggestive symptoms with a right lower quadrant mass confirmed on X-ray. The main differential is chronic constipation. Treatment consists of rehydration combined with stool softening laxatives or gut lavage with balanced electrolyte solutions. Rapid fluid shifts have been described following osmotic agents. Avoiding dehydration and optimizing pancreatic enzyme dosage may reduce the chance of further episodes. Prophylactic laxative therapy is widely used, but is not evidence-based.
Copyright © 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21658638     DOI: 10.1016/S1569-1993(11)60005-2

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  33 in total

1.  Distal intestinal obstructive syndrome (DIOS): a gastrointestinal complication of cystic fibrosis in adults.

Authors:  Marianna Mavilia
Journal:  Clin J Gastroenterol       Date:  2019-04-08

Review 2.  Gastrointestinal Manifestations of Cystic Fibrosis.

Authors:  Thomas Kelly; James Buxbaum
Journal:  Dig Dis Sci       Date:  2015-02-04       Impact factor: 3.199

Review 3.  Beyond pancreatic insufficiency and liver disease in cystic fibrosis.

Authors:  Stephanie Demeyer; Kris De Boeck; Peter Witters; Katrien Cosaert
Journal:  Eur J Pediatr       Date:  2016-04-07       Impact factor: 3.183

4.  Intraoperative intraluminal injection of N-acetylcysteine allowing treatment of distal intestinal obstruction syndrome without the need for enterotomy.

Authors:  Nicholas Js Chilvers; James Wheeler
Journal:  BMJ Case Rep       Date:  2018-05-16

5.  Gastrointestinal surgery in adult patients with cystic fibrosis.

Authors:  Abhiram Sharma; Alison Morton; Daniel Peckham; David Jayne
Journal:  Frontline Gastroenterol       Date:  2012-07-13

Review 6.  N-acetylcysteine for Management of Distal Intestinal Obstruction Syndrome.

Authors:  Abigail L Schauble; Elizabeth K Bisaccia; Grace Lee; Samya Z Nasr
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Sep-Oct

Review 7.  Luminal Gastrointestinal Manifestations of Cystic Fibrosis.

Authors:  Samuel J Burton; Christine Hachem; James M Abraham
Journal:  Curr Gastroenterol Rep       Date:  2021-03-23

8.  Gastrointestinal Manifestations of Cystic Fibrosis.

Authors:  Sabina Sabharwal
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-01

Review 9.  Meconium Ileus.

Authors:  John H T Waldhausen; Morgan Richards
Journal:  Clin Colon Rectal Surg       Date:  2018-02-25

10.  Swimming through the gut: implications of fluid transport on the microbiome.

Authors:  Sean P Colgan
Journal:  Dig Dis Sci       Date:  2013-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.